Company Filing History:
Years Active: 2025
Title: David J Witter: Innovator in PRMT5 Inhibitors
Introduction
David J Witter is a notable inventor based in California, recognized for his contributions to the field of pharmaceuticals. He has developed innovative compounds that have the potential to treat serious health conditions, including cancer and genetic disorders.
Latest Patents
Witter holds a patent for PRMT5 inhibitors, which includes a compound of Formula (I) and its pharmaceutically acceptable salts, esters, and prodrugs. This invention outlines methods for creating these compounds, as well as pharmaceutical compositions that utilize them. The applications of these compounds are significant, as they can be used to treat cancer, sickle cell disease, and hereditary persistence of fetal hemoglobin (HPFH) mutations.
Career Highlights
David J Witter is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to focus on developing innovative solutions that address critical health challenges.
Collaborations
Witter has collaborated with esteemed colleagues, including Michelle R Machacek and Michael D Altman, to advance his research and development efforts in the pharmaceutical field.
Conclusion
David J Witter's contributions to the development of PRMT5 inhibitors highlight his commitment to innovation in healthcare. His work has the potential to make a significant impact on the treatment of various diseases.